DSI Alyoss Plus- Bone-Grafting

Regenerative solutionsRoyal Dent
DSI Alyoss Plus- Bone-Grafting
0 comments

DSI Alyoss Plus is an allograft material made up of cortical and cancellous bone. The material is packaged in a ready-to-use syringe, making for a quick and easy delivery method. The bone is extracted from sections of the illium and ground into a variety of particle sizes, resulting in a one-of-a-kind blend. DSI Alyoss Plus, as a cortico-cancellous allograft, provides excellent structural support to the site of treatment while inducing rapid new bone formation. The cancellous bone's porous architecture acts as a scaffold, encouraging the ingrowth of bone vessels containing pre-osteoblastic and mesenchymal cells, promoting osteoconduction and accelerating revascularization. The cortical component contributes to the structural strength and support of the affected site due to its superior strength. DSI Alyoss Plus is a viable alternative to using a patient's autogenous graft, with a number of significant advantages. The material eliminates the need for a second surgical site, thereby eliminating the possibility of complications and infections, post-operative pain, additional anesthesia, and a longer healing process.

DSI Alyoss Plus is an excellent combination that provides this product with the ideal cell structure of cortical bone as well as an open scaffold and support provided by cancellous bone. All DSI Biomaterials are manufactured in accordance with stringent international standards. Numerous treatment sequences and exceptional measures ensure complete safety and high bone quality. Only EU-registered tissue banks are used as a source, and almost all donors are subjected to extensive screening and testing before being accepted into the banks. Following that, the bone is processed into DBM (Demineralized Bone Matrix) in highly innovative facilities using aseptic techniques to avoid cross-contamination and meet strict release standards. The final step in the manufacturing process is gamma sterilization, which results in a clinically effective product that is immune neutral.

The material's numerous advantageous properties make it ideal for sinus augmentation. The sinus floor can be more precisely adjusted with DSI Alyoss Plus, it is more biocompatible than other bone materials, and the healing process is faster and more predictable. The syringe ensures accurate and controlled placement for easier maxillary sinus filling during the sinus lift. DSI Alyoss Plus can be used alone or in combination with autogenous bone to improve the graft's osteoinductive properties.

Product SKU's

DSI Alyoss Plus, Syringe 0.25cc- AG25
DSI Alyoss Plus, Syringe 0.50cc- AG50
DSI Alyoss Plus, Syringe 1.0cc- AG100

Procedure for Handling

  1. Remove double or triple wrapping and using aseptic technique to avoid contamination. Check for any damages on the inner packaging
  2. Microbiological culture testing is recommended before the allograft tissue is soaked using saline solution
  3. Rehydrate the allograft at basin containing sterilized solution
  4. Rehydation of the allograft is recommended for more than 30 minutes
  5. The product should be cleansed for about 3 times by changing the solution to remove any remaining reagents
  6. All preparations should be carried out before transplanting the allograft

Features

  • A corticocancellous mixture in a syringe
  • Excellent clinical outcomes
  • Excellent quality
  • dependable and safe
  • Extremely biocompatible
  • There was no immunogenic reaction.
  • Scaffolding for osteoconductive use
  • New bone growth is accelerating.
  • Handling that is both convenient and clean
  • Time-saving and simple to use
  • Only qualified donors from EU-registered tissue banks were used after extensive screening.

Benefits

  • Cortical/Cancellous blend combines two of the most popular allograft particles used in dentistry, all in one syringe
  • Allograft bone particulates supply a natural framework facilitating the attachment of osteogenic precursor cells.
  • Safe alternative to an autograft with no need for a second surgical site.
  • Used for volumetric enhancement, space maintenance and faster remodeling.

Use of Alyoss and Zenoss Matrix at lateral tooth replacement video process:

 For more info,

Tags: Regenerative solutions

Leave a comment

All comments are moderated before being published

Featured Product

View More
DSI Alyoss Natural Allograft Cancellous Cortical Bone Graft Material In Syringe
DSI Alyoss Natural Allograft Cancellous Cortical Bone Graft Material In Syringe
DSI Alyoss Natural Allograft Cancellous Cortical Bone Graft Material In Syringe
DSI Alyoss Natural Allograft Cancellous Cortical Bone Graft Material In SyringeDSI Alyoss Natural Allograft Cancellous Cortical Bone Graft Material In SyringeDSI Alyoss Natural Allograft Cancellous Cortical Bone Graft Material In Syringe

DSI Alyoss Natural Allograft Cancellous Cortical Bone Graft Material In Syringe

DSI Alyoss is the highest quality allograft bone material. It is a composition of a blend of cortical and cancellous bone and is presented in a convenient, ready-to-use syringe. DSI Alyoss is completely safe and the high quality of the bone is ensured by numerous treatment sequences and exceptional measures. It may be used on its own or mixed with an autogenous bone in order to increase the osteoinductive properties of the graft.

DSI Alyoss is a viable alternative to using an autogenous graft from the patient, bringing a number of significant benefits. No need for a second surgery, along with potential complications and infections, postoperative pain, additional anesthesia, and a longer healing process.

DSI Alyoss is harvested from sections of the ilium and ground into several particulate sizes, resulting in a unique mix. This blend of the cancellous bone’s porous architecture supplies a scaffold, promoting osteoconduction and accelerating revascularization. All of that is done while the cortical element provides a lamellar structure, possessing density and strength similar to that of the patient's own bone.

Only EU-registered tissue banks are used as a source, where virtually all the donors undergo stringent screening and extensive tests before being accepted into the banks. After that, the bone is processed into DBM (Demineralized Bone Matrix) to expose osteoinductive growth factors in highly innovative facilities under an aseptic technique to avoid any possible cross-contamination and to meet strict release standards. The last step of the production is gamma sterilization to deliver a clinically effective product, neutral to the immune reactions of the host.


Indications:

  • Augmentation or reconstructive treatment of the alveolar ridge.
  • Filling of bony periodontal defects.
  • Filling of defects after root resection, apicoectomy, and cystectomy.
  • Filling of extraction sockets to enhance preservation of the alveolar ridge.
  • Sinus-lifting.
  • Filling of periodontal defects in conjunction with products intended for Guided
  • Tissue Regeneration (GTR).
  • Guided Bone Regeneration (GBR).
  • Filling of peri-implant defects

Features:

  • Convenient handling
  • Only qualified donors from EU-registered tissue banks after a rigorous screening
  • Promoting osteoconduction and accelerating revascularization
  • Similar to that of the patient's own bone
  • Gamma sterilized
  • May be used on its own or mixed with an autogenous bone
  • Cortical and cancellous blend
  • Excellent clinical results
  • Top-quality
  • Safe and reliable
  • Highly biocompatible
  • No immunogenic reaction
  • The rapid growth of the new bone


How to use:

The freeze-dried product should be kept within the set temperature for storing prior to use and each product should be rehydrated individually.
1. Remove double - or triple - wrapping (including outer packaging) and use an aseptic technique to remove the inner packaging to the practitioner with sterile surgical attire to avoid contamination.
2. Check for any damages on the inner packaging.
3. Microbiological culture testing is recommended before the allograft tissue is soaked using a saline solution.
4. Rehydrate the allograft in at basin containing sterilized solution (physiological saline solution, lactic acid, ringer's solution) or any other appropriate antibiotic solution of your preference. The rehydrated allograft should be refrigerated between 1 to 8° C prior to transplantation.
5. Rehydration of the allograft for more than 30 minutes is recommended (Stir the solution using a long sterilized rod for 15 seconds).
6. The product should be cleaned about 3 times by changing the solution to remove any remaining reagents.
7. All preparations should be carried out before transplanting the allograft.

 Package:

REF Content
AG25
 0.25cc bone graft in a syringe
AG50
 0.50cc bone graft in a syringe
AG100
 1.00cc bone graft in a syringe
Size: 0.25cc
Price:
$97.90